Zepp Health’s Q1 2025 Results Show Growth in Amazfit Sales Amid Strategic Initiatives

Zepp Health ( (ZEPP) ) has issued an update.

Zepp Health Corporation reported its unaudited financial results for the first quarter of 2025, showing a revenue of $39 million, with a 10.2% year-over-year growth in Amazfit-branded products. Despite a net loss of $19.7 million due to the traditionally low sales season, the company maintained a gross margin of 37.3% and a cash balance of $104 million. Zepp Health’s strategic initiatives, including a dual-sourcing supply chain and AI-driven product enhancements, position it for growth, with expected revenue increases in the second quarter of 2025. The company also expanded its product lineup with successful launches of the Amazfit Active 2 and Bip 6, which have been well-received in the market.

The most recent analyst rating on (ZEPP) stock is a Buy with a $20.76 price target. To see the full list of analyst forecasts on Zepp Health stock, see the ZEPP Stock Forecast page.

Spark’s Take on ZEPP Stock

According to Spark, TipRanks’ AI Analyst, ZEPP is a Neutral.

Zepp Health’s overall stock score reflects a challenging financial position with declining revenues and profitability, offset by promising strategic initiatives and product launches that have improved recent sales growth and gross margins. Despite the positive developments, financial leverage and ongoing losses pose significant risks, with technical and valuation metrics suggesting caution. Strategic management is crucial for sustained improvement.

To see Spark’s full report on ZEPP stock, click here.

More about Zepp Health

Zepp Health Corporation operates in the wearable technology industry, primarily offering smartwatches and fitness trackers under the Amazfit brand. The company focuses on leveraging open-source technologies and AI to enhance product features and expand its market presence globally.

Average Trading Volume: 26,364

Technical Sentiment Signal: Sell

Current Market Cap: $41.18M

For an in-depth examination of ZEPP stock, go to TipRanks’ Stock Analysis page.